We are live on ! Find out more
THRX

Theseus Pharmaceuticals, Inc. Common Stock
THRX

Delisted

THRX was delisted on the 13th of February, 2024.

Back to rankings

46 hedge funds and large institutions have $441M invested in Theseus Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 46 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+46
Holders Change %
–
% of All Funds
0.71%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.06%
New
46
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$254M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$82.3M
3
FCMV
Foresite Capital Management V
California
+$48.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$19.6M
5
BC
Boxer Capital
California
+$13.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$281K +$334K +22,136 New
N
27
Nuveen
North Carolina
$222K +$264K +17,494 New
Bank of New York Mellon
28
Bank of New York Mellon
New York
$217K +$259K +17,160 New
CCM
29
CAAS Capital Management
New York
$190K +$226K +15,000 New
ZP
30
Zimmer Partners
New York
$190K +$226K +15,000 New
AGM
31
Alpine Global Management
New York
$144K +$171K +11,340 New
Morgan Stanley
32
Morgan Stanley
New York
$123K +$146K +9,679 New
Bank of America
33
Bank of America
North Carolina
$100K +$119K +7,906 New
Deutsche Bank
34
Deutsche Bank
Germany
$89K +$106K +6,993 New
Wells Fargo
35
Wells Fargo
California
$86K +$102K +6,774 New
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$80K +$95.5K +6,325 New
AIG
37
American International Group
New York
$78K +$92.3K +6,116 New
JP Morgan Chase
38
JP Morgan Chase
New York
$65K +$77.1K +5,108 New
UBS Group
39
UBS Group
Switzerland
$45K +$53.9K +3,568 New
Citigroup
40
Citigroup
New York
$40K +$47.5K +3,147 New
SO
41
STRS Ohio
Ohio
$34K +$40.8K +2,700 New
Royal Bank of Canada
42
Royal Bank of Canada
Ontario, Canada
$29K +$34.5K +2,282 New
TRCT
43
Tower Research Capital (TRC)
New York
$27K +$32K +2,120 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$21K +$24.9K +1,651 New
Legal & General Group
45
Legal & General Group
United Kingdom
$13K +$16K +1,059 New
AIP
46
Ameritas Investment Partners
Nebraska
$11K +$13.4K +889 New
1
2

THRX Hedge Fund Activity: Q4 2021 in Review

46 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Theseus Pharmaceuticals, Inc. Common Stock (THRX) for Q4 2021, worth a combined $441M.

Buyers outnumbered sellers: 46 funds opened new THRX positions and 0 closed out — a net gain of 46 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $254M.

  • 46 institutional investors held Theseus Pharmaceuticals, Inc. Common Stock (THRX) as of Q4 2021, up from 0 in Q3 2021.
  • Funds reported $441M of Theseus Pharmaceuticals, Inc. Common Stock stock for Q4 2021.
  • 46 funds opened new Theseus Pharmaceuticals, Inc. Common Stock positions in Q4 2021 and 0 closed out, a net change of +46 holders.
  • The largest Theseus Pharmaceuticals, Inc. Common Stock buyer in Q4 2021 was OrbiMed, an estimated $254M added.

Based on aggregated 13F filings for Q4 2021.